Cell therapy in critical limb ischemia: Current developments and future progress

Cytotherapy

Volumn 14, Issue 8, 2012, Pages 902-916

  Mamidi, Murali Krishna ^a,b   Pal, Rajarshi ^b   Dey, Sovan ^c   Bin Abdullah, Basri Johan Jeet ^d   Zakaria, Zubaidah ^e   Rao, Mahendra S ^f   Das, Anjan Kumar ^a  

^a Stempeutics Research Malaysia Sdn Bhd   (Malaysia)

^b Manipal Academy of Higher Education   (India)

^c LA TROBE UNIVERSITY   (Australia)

^d UNIVERSITY OF MALAYA   (Malaysia)

^e INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Angiogenesis; Animal studies; Cell replacement therapy; Clinical trials; Critical limb ischemia; Peripheral artery disease; Stem cells

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANGIOGENESIS; ATHEROSCLEROSIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD FLOW; BUERGER DISEASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; CELL TRANSPLANTATION; CLASSIFICATION; DISEASE MODEL; EMBRYONIC STEM CELL; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; HUMAN; IN VIVO STUDY; LEG REVASCULARIZATION; LIMB AMPUTATION; LIMB ISCHEMIA; LIMB SALVAGE; MORBIDITY; MORTALITY; NONHUMAN; PERINATAL PERIOD; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SURVIVAL; ULCER HEALING;

EID: 84866073406     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653249.2012.693156     Document Type: Review

References (119)

1. Hirsch AT. Critical limb ischemia and stem cell research: anchoring hope with informed adverse event reporting. Circulation. 2006;12;114:2581-3.
2. O'Hare AM, Bertenthal D, Sidawy AN, et al. Renal insufficiency and use of revascularization among a national cohort of men with advanced lower extremity peripheral arterial disease. Clin J Am Soc Nephrol. 2006;1:297-304.
3. Rowe VL, Lee W, Weaver FA, et al. Patterns of treatment for peripheral arterial disease in the United States:1996-2005. J Vasc Surg. 2009;49:910-7.
4. Kudo T, Chandra FA, Kwun WH, et al. Changing pattern of surgical revascularization for critical limb ischemia over 12 years: endovascular vs. open bypass surgery. J Vasc Surg. 2006;44:304-13.
5. Romiti M, Albers M, Brochado-Neto FC, et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008;47:975-81.
6. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5-67.
7. Marston WA, Davies SW, Armstrong B, et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg. 2006;44:108-14.
8. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-7.
9. Shi Q, Rafii S, Wu MH, et al. Evidence for circulating bone marrow-derived endothelial cells. Blood. 1998;92:362-7.
10. Brey EM, Uriel S, Greisler HP, et al. Therapeutic neovascularization: contributions from bioengineering. Tissue Eng. 2005;11:567-84.
11. Augustin HG. Tubes branches and pillars: the many ways of forming a new vasculature. Circ Res. 2001;89:645-7.
12. Hirschi K, Goodell M. Common origins of blood and blood vessels in adults? Differentiation. 2001;68:186-92.
13. Burns TC, Verfaillie CM, Low WC. Stem cells for ischemic brain injury: a critical review. J Comp Neurol. 2009;515:125-44.
14. Lindvall O, Kokaia Z. Stem cells for the treatment of neurological disorders. Nature. 2006;441:1094-6.
15. Campagnolo P, Cesselli D, Al Haj Zen A, et al. Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation. 2010;121:1735-45.
16. Sasagawa T, Shimizu T, Sekiya S, et al. Design of prevascularized three-dimensional cell-dense tissues using a cell sheet stacking manipulation technology. Biomaterials. 2010;31:1646-54.
17. Bonfield TL, Nolan Koloze MT, Lennon DP, et al. Defining human mesenchymal stem cell efficacy in vivo. J Inflamm (Lond). 2010;7:51.
18. Ortiz LA, Gambelli F, McBride C, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA. 2003;100:8407-11.
19. Mei SH, Haitsma JJ, Dos Santos CC, et al. Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med. 2010;182:1047-57.
20. Daley GQ. Stem cells: roadmap to the clinic. J Clin Invest. 2010;120:8-10.
21. Kaufman DS, Lewis RL, Hanson ET, et al. Functional endothelial cells derived from rhesus monkey embryonic stem cells. Blood. 2004;103:1325-32.
22. Wang ZZ, Au P, Chen T, et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol. 2007;25:317-8.
23. Saeki K, Yogiashi Y, Nakahara M, et al. Highly efficient and feeder-free production of subculturable vascular endothelial cells from primate embryonic stem cells. J Cell Physiol. 2008;217:261-80.
24. Li Z, Wilson KD, Smith B, et al. Functional and transcriptional characterization of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. PLoS One. 2009;4(12):e8443.
25. Mariappan D, Winkler J, Chen S, et al. Transcriptional profiling of CD31 (+) cells isolated from murine embryonic stem cells. Genes Cells. 2009;14:243-60.
26. Kane NM, Xiao Q, Baker AH, et al. Pluripotent stem cell differentiation into vascular cells: a novel technology with promises for vascular re (generation). Pharmacol Ther. 2011;129:29-49.
27. Levenberg S, Golub JS, Amit M, et al. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA. 2002;99:4391-6.
28. Zambidis ET, Peault B, Park TS, et al. Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood. 2005;106:860-70.
29. + cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood. 2005;105:617-26.
30. Ferreira LS, Gerecht S, Shieh HF, et al. Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res. 2007;101:286-94.
31. Yamashita J, Itoh H, Hirashima M, et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature. 2000;408:92-6.
32. Sone M, Itoh H, Yamashita J, et al. Different differentiation kinetics of vascular progenitor cells in primate and mouse embryonic stem cells. Circulation. 2003;107:2085-8.
33. + progenitors derived from embryonic stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Arterioscler Thromb Vasc Biol. 2006;26:2244-51.
34. Nakagami H, Nakagawa N, Takeya Y, et al. Model of vasculogenesis from embryonic stem cells for vascular research and regenerative medicine. Hypertension. 2006;48:112-9.
35. Cho SW, Moon SH, Lee SH, et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hind limb ischemia. Circulation. 2007;116:2409-19.
36. Huang H, Zhao X, Chen L, et al. Differentiation of human embryonic stem cells into smooth muscle cells in adherent monolayer culture. Biochem Biophys Res Commun. 2006;351(2):321-7.
37. Lu SJ, Ivanova Y, Feng Q, et al. Hemangioblasts from human embryonic stem cells generate multilayered blood vessels with functional smooth muscle cells. Regen Med. 2009;4:37-47.
38. Sone M, Itoh H, Yamahara K, et al. Pathway for differentiation of human embryonic stem cells to vascular cell components and their potential for vascular regeneration. Arterioscler Thromb Vasc Biol. 2007;27:2127-34.
39. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-76.
40. Aoi T, Yae K, Nakagawa M, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science. 2008;321:699-702.
41. Stadtfeld M, Nagaya M, Utikal J, et al. Induced pluripotent stem cells generated without viral integration. Science. 2008;322:945-9.
42. Park IH, Arora N, Huo H, et al. Disease-specific induced pluripotent stem cells. Cell. 2008;134:877-86.
43. Dimos JT, Rodolfa KT, Niakan KK, et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008;321:1218-21.
44. Homma K, Sone M, Taura D, et al. Sirt1 plays an important role in mediating greater functionality of human ES/iPSderived vascular endothelial cells. Atherosclerosis. 2010;212:42-7.
45. Rufaihah AJ, Huang NF, Jame S, et al. Endothelial cells derived from human iPSCs increase capillary density and improve perfusion in a mouse model of peripheral arterial disease. Arterioscler Thromb Vasc Biol. 2011;31:e72-9.
46. Hmadcha A, Dominguez-Bendala J, Wakeman J, et al. The immune boundaries for stem cell based therapies: problems and prospective solutions. J Cell Mol Med. 2009;13:1464-75.
47. + murine bone marrow low-adherent mesenchymal primitive cells preserve multilineage differentiation potential in long-term in vitro culture. Mol Cells. 2011;31:497-507.
48. Fan W, Crawford R, Xiao Y. The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization. Differentiation. 2011;81:181-91.
49. + progenitors derived from bone mesenchymal stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Cell Reprogram. 2010;12:405-15.
50. Birnbaum T, Hildebrandt J, Nuebling G, et al. Glioblastomadependent differentiation and angiogenic potential of human mesenchymal stem cells in vitro. J Neurooncol. 2011;105:57-65.
51. Benameur T, Tual-Chalot S, Andriantsitohaina R, et al. PPARalpha is essential for microparticle-induced differentiation of mouse bone marrow-derived endothelial progenitor cells and angiogenesis. PLoS One. 2010;5(8):e12392.
52. Aguiari P, Leo S, Zavan B, et al. High glucose induces adipogenic differentiation of muscle-derived stem cells. Proc Natl Acad Sci USA. 2008;105:1226-31.
53. Gardin C, Bressan E, Ferroni L, et al. In vitro concurrent endothelial and osteogenic commitment of adipose-derived stem cells and their genomical analyses through comparative genomic hybridization array: novel strategies to increase the successful engraftment of tissue-engineered bone grafts. Stem Cells Dev. 2012;21:767-77.
54. + human cord blood fraction for effective therapeutic vascularization. FASEB J. 2011;25:159-69.
55. Lavergne M, Vanneaux V, Delmau C, et al. Cord bloodcirculating endothelial progenitors for treatment of vascular diseases. Cell Prolif. 2011;44(Suppl 1):44-7.
56. Kimura T, Kohno H, Matsuoka Y, et al. CXCL8 enhances the angiogenic activity of umbilical cord blood-derived outgrowth endothelial cells in vitro. Cell Biol Int. 2011;35:201-8.
57. Marchionni C, Bonsi L, Alviano F, et al. Angiogenic potential of human dental pulp stromal (stem) cells. Int J Immunopathol Pharmacol. 2009;22:699-706.
58. Sugiyama M, Iohara K, Wakita H, et al. Dental pulp-derived CD31-/CD146 - side population stem/progenitor cells enhance recovery of focal cerebral ischemia in rats. Tissue Eng Part A. 2011;17:1303-11.
59. Nakano-Doi A, Nakagomi T, Fujikawa M, et al. Bone marrow mononuclear cells promote proliferation of endogenous neural stem cells through vascular niches after cerebral infarction. Stem Cells. 2010;28:1292-302.
60. De Luca A, Gallo M, Aldinucci D, et al. Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells. J Cell Physiol. 2011;226:2131-8.
61. Chung NA, Lydakis C, Belgore F, et al. Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease. Heart. 2003;89:1411-5.
62. Moulton KS. Plaque angiogenesis and atherosclerosis. Curr Atheroscler Rep. 2001;3:225-33.
63. Masaki I, Yonemitsu Y, Yamashita A, et al. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res. 2002;90:966-73.
64. Shiojima I, Walsh K. Role of Akt signaling in vascular homeostasis and angiogenesis. Circ Res. 2002;90:1243-50.
65. Donnini S, Ziche M. Constitutive and inducible nitric oxide synthase: role in angiogenesis. Antioxid Redox Signal. 2002;4:817-23.
66. Deregibus MC, Cantaluppi V, Calogero R, et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood. 2007;110:2440-8.
67. Rossig L, Jadidi AS, Urbich C, et al. Akt-dependent phosphorylation of p21 (Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol Cell Biol. 2001;21:5644-57.
68. Levkau B, Koyama H, Raines EW, et al. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell. 1998;1:553-63.
69. Chavakis E, Dimmeler S. Regulation of endothelial cell survival and apoptosis during angiogenesis. Arterioscler Thromb Vasc Biol. 2002;22:887-93.
70. Cheng T, Rodrigues N, Shen H, et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science. 2000;287:1804-8.
71. Santiago-Raber ML, Lawson BR, Dummer W, et al. Role of cyclin kinase inhibitor p21 in systemic autoimmunity. J Immunol. 2001;167:4067-74.
72. Martin-Caballero J, Flores JM, Garcia-Palencia P, et al. Tumor susceptibility of p21 (Waf1/Cip1)-deficient mice. Cancer Res. 2001;61:6234-8.
73. Bruhl T, Heeschen C, Aicher A, et al. p21Cip1 levels differentially regulate turnover of mature endothelial cells, endothelial progenitor cells, and in vivo neovascularization. Circ Res. 2004;94:686-92.
74. Jackson KA, Majka SM, Wang H, et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001;107:1395-402.
75. Iba O, Matsubara H, Nozawa Y, et al. Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs. Circulation. 2002;106:2019-25.
76. Hur J, Yoon CH, Kim HS, et al. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol. 2004;24:288-93.
77. Yoon CH, Hur J, Oh IY, et al. Intercellular adhesion molecule-1 is upregulated in ischemic muscle, which mediates trafficking of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2006;26:1066-72.
78. Kim HK, Song KS, Chung JH, et al. Platelet microparticles induce angiogenesis in vitro. Br J Haematol. 2004;124:376-84.
79. Deregibus MC, Cantaluppi V, Calogero R, et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood. 2007;10:2440-8.
80. Vidavalur R, Penumathsa SV, Zhan L, et al. Sildenafil induces angiogenic response in human coronary arteriolar endothelial cells through the expression of thioredoxin, hemeoxygenase and vascular endothelial growth factor. Vascul Pharmacol. 2006;45:91-5.
81. Minamino K, Adachi Y, Okigaki M, et al. Macrophage colonystimulating factor (M-CSF), as well as granulocyte colony-stimulating factor (G-CSF), accelerates neovascularization. Stem Cells. 2005;23:347-54.
82. Oh IY, Yoon CH, Hur J, et al. Involvement of E-selectin in recruitment of endothelial progenitor cells and angiogenesis in ischemic muscle. Blood. 2007;110:3891-9.
83. Brill A, Dashevsky O, Rivo J, et al. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res. 2005;67:30-8.
84. Lacroix R, Sabatier F, Mialhe A, et al. Activation of plasminogen into plasmin at the surface of endothelial microparticles: a mechanism that modulates angiogenic properties of endothelial progenitor cells in vitro. Blood. 2007;110:2432-9.
85. Soleti R, Benameur T, Porro C, et al. Microparticles harboring sonic hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors. Carcinogenesis. 2009;30:580-8.
86. Tabernero A, Schoonjans K, Jesel L, et al. Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation. BMC Pharmacol. 2002;2:10.
87. Biscetti F, Gaetani E, Flex A, et al. Peroxisome proliferatoractivated receptor alpha is crucial for iloprost-induced in vivo angiogenesis and vascular endothelial growth factor upregulation. J Vasc Res. 2009;46:103-8.
88. Luque Contreras D, Vargas Robles H, Romo E, et al. The role of nitric oxide in the post-ischemic revascularization process. Pharmacol Ther. 2006;112:553-63.
89. Moon JJ, Lee SH, West JL. Synthetic biomimetic hydrogels incorporated with ephrin-A1 for therapeutic angiogenesis. Biomacromolecules. 2007;8:42-9.
90. Rey S, Luo W, Shimoda LA, et al. Metabolic reprogramming by HIF-1 promotes the survival of bone marrowderived angiogenic cells in ischemic tissue. Blood. 2011;117:4988-98.
91. Oda E, Kawai R, Aizawa Y. Lymphocyte count was significantly associated with hyper-LDL cholesterolemia independently of high-sensitivity C-reactive protein in apparently healthy Japanese. Heart Vessels. 2011. Jun. 8. [Epub ahead of print].
92. Gulati R, Simari RD. Defining the potential for cell therapy for vascular disease using animal models. Dis Model Mech. 2009;2:130-7.
93. Crosby JR, Kaminski WE, Schatteman G, et al. Endothelial cells of haematopoetic origin make a significant contribution to adult blood vessel formation. Circ Res. 2000;87:728-30.
94. Layman H, Rahnemai-Azar AA, Pham SM, et al. Synergistic angiogenic effect of codelivering fibroblast growth factor 2 and granulocyte-colony stimulating factor from fibrin scaffolds and bone marrow transplantation in critical limb ischemia. Tissue Eng Part A. 2011;17:243-54.
95. Murohara T, Ikeda H, Duan J, et al. Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest. 2000;105:1527-36.
96. Shintani S, Murohara T, Ikeda H, et al. Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation. 2001;103:897-903.
97. Yoshida M, Horimoto H, Mieno S, et al. Intra-arterial bone marrow cell transplantation induces angiogenesis in rat hindlimb ischemia. Eur Surg Res. 2003;35:86-91.
98. Chen J, Zhang ZG, Li Y, et al. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res. 2003;92:692-9.
99. Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral arterial disease critical appraisal. Thromb Haemost. 2010;103:696-709.
100. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischemia by autologous transplantation of bone-marrow cells: a pilot study and a randomized controlled trial. Lancet. 2002;360:427-35.
101. Walter DH, Krankenberg H, Balzer J, et al. Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebocontrolled pilot trial (PROVASA). Circ Cardiovas Interv. 2011;4:26-37.
102. Gupta R, Losordo DW. Cell therapy for critical limb ischemia: moving forward one step at a time. Circ Cardiovasc Interv. 2011;4:2-5.
103. Nishioka K, Hidaka T, Kihara Y, et al. Autologous bone-marrow mononuclear cell implantation reduces longterm major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease. Circ Cardiovasc Interv. 2011;4:15-25.
104. Murphy MP, Lawson JH, Rapp BM, et al. Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia. J Vasc Surg. 2011;53:1565-74.
105. Lu D, Chen B, Liang Z, et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. Diabetes Res Clin Pract. 2011;92:26-36.
106. Miyamoto K, Nishigami K, Nagaya N, et al. Unblinded pilot study of autologous transplantation of bone marrow mononuclear cells in patients with thromboangiitisobliterans. Circulation. 2006;114:2679-84.
107. Gopurappilly R, Pal R, Mamidi MK, et al. Stem cells in stroke repair: current success and future prospects. CNS Neurol Disord Drug Targets. 2011;10:741-56.
108. Garcia-Olmo D, Herreros D, De-La-Quintana P, et al. Adiposederived stem cells in Crohn's rectovaginal fistula. Case Report Med. 2010;2010:961758.
109. Sprengers RW, Lips DJ, Moll FL, et al. Progenitor cell therapy in patients with critical limb ischemia without surgical options. Ann Surg. 2008;47:411-20.
110. Mizuno H, Miyamoto M, Shimamoto M, et al. Therapeutic angiogenesis by autologous bone marrow cell implantation together with allogeneic cultured dermal substitute for intractable ulcers in critical limb ischaemia. J Plast Reconstr Aesthet Surg. 2010;63:1875-82.
111. ™) following acute myocardial infarction. J Am Coll Cardiol. 2009;54:2277-86.
112. Zhou B, Poon MC, Pu WT, et al. Therapeutic neovascularization for peripheral arterial diseases: advances and perspectives. Histol Histopathol. 2007;22:677-86.
113. Amann B, Ludemann C, Ruckert R, et al. Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: The Bone Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI). J Vas. Dis. 2008;37:319-25.
114. Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest. 2005;115:572-83.
115. Bartsch T, Brehm M, Zeus T, et al. Autologous mononuclear stem cell transplantation in patients with peripheral occlusive arterial disease. J Cardiovasc Nurs. 2006;21:430-32.
116. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913-8.
117. Van Tongeren RB, Hamming JF, Fibbe WE, et al. Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J Cardiovas Surg. 2008;49:51-8.
118. Ruiz-Salmeron R, de la Cuesta-Diaz A, Constantino-Bermejo M, et al. Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia. Cell Transplant. 2011;20:1629-39.
119. Saigawa T, Kato K, Ozawa T, et al. Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J. 2004;68:1189-93.